|
Previous: CURAGEN CORP, 10-K, 2000-03-07 |
Next: CURAGEN CORP, 10-K, 2000-03-07 |
EXHIBIT 11 |
||||||||||
CURAGEN CORPORATION |
||||||||||
COMPUTATION OF NET LOSS PER SHARE |
||||||||||
ATTRIBUTABLE TO COMMON STOCKHOLDERS |
||||||||||
Year Ended December 31, |
||||||||||
|
||||||||||
1997 |
1998 |
1999 |
||||||||
|
|
|
||||||||
Net loss | ($7,222,010) |
($18,428,485) |
($25,762,760) |
|||||||
Preferred dividends | (68,424) |
(508,435) |
- |
|||||||
|
|
|
||||||||
Net loss attributable to common stockholders | ($7,290,434) |
($18,936,920) |
($25,762,760) |
|||||||
|
|
|
||||||||
Basic and diluted net loss per share attributable | ||||||||||
to common stockholders | $(0.92) |
$(1.55) |
$(1.79) |
|||||||
|
|
|
||||||||
Weighted average number of shares used in | ||||||||||
computing basic and diluted net loss per share | ||||||||||
attributable to common stockholders | 7,888,383
|
12,201,006 |
14,400,992 |
|||||||
|
|
|
|